MRK vs CI
By Alex · Tickerpine
Merck & Co., Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CI |
|---|---|---|
| Price | $156.45 | $279.32 |
| Market cap | $385.99B | $73.81B |
| P/E ratio | 120.3 | 11.6 |
| ROE | 6.96% | 16.76% |
| Profit margin | 4.77% | 2.27% |
| Revenue growth | 5.10% | 6.70% |
| Dividend yield | 2.26% | 2.22% |
| Beta | 0.21 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CI in plain English
- MRK is the bigger company — about 5.2× the market cap of CI.
- CI is cheaper on earnings (P/E 11.6 vs 120.3).
- CI earns a higher return on equity (17% vs 7%).
- CI is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.26% vs 2.22%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.